<DOC>
	<DOCNO>NCT00621153</DOCNO>
	<brief_summary>To compare change mean sit DBP baseline 4 week therapy either candesartan cilexetil/HCT combination therapy candesartan cilexetil monotherapy regimen</brief_summary>
	<brief_title>Candesartan Effect Second Stage Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Stage II essential hypertension ( SBP≥ 160 DBP≥100 mmHg ) , untreated , treat maximum 2 class antihypertensive drug Current serumcreatinine &gt; 3 mg/dL , Current serumpotassium &gt; 5.5 mmol/L , 16 . Pregnant lactate woman woman childbearing potential protected pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Candesartan Cilexetil</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>severe hypertension</keyword>
</DOC>